Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-7977/GS-5885 FDC in HIV/HCV Coinfection
NCT01878799Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir, sofosbuvir in hepatitis C (HCV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2013; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01878799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878799.